Apellis Pharmaceuticals
APLS
APLS
145 hedge funds and large institutions have $1.85B invested in Apellis Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 49
7% less capital invested
Capital invested by funds: $2B → $1.85B (-$149M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
145
Holding in Top 10
3
Calls
$4.72M
Puts
$3.67M
Top Buyers
| 1 | +$25.1M | |
| 2 | +$21.4M | |
| 3 | +$18.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$17.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$16.2M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$25.1M | |
| 3 | -$10.2M | |
| 4 |
Two Sigma Investments
New York
|
-$7.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.94M |